Pfizer Inc. (PFE)
Largest Insider Buys in Sector
PFE Stock Price History Chart
PFE Stock Performance
About Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Activity of Pfizer Inc.
Over the last 12 months, insiders at Pfizer Inc. have bought $79,401 and sold $0 worth of Pfizer Inc. stock.
On average, over the past 5 years, insiders at Pfizer Inc. have bought $334,165 and sold $20.64M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Gottlieb Scott (director) — $79,401.
The last purchase of 3,000 shares for transaction amount of $79,401 was made by Gottlieb Scott (director) on 2023‑12‑15.
List of Insider Buy and Sell Transactions, Pfizer Inc.
| 2023-12-15 | Gottlieb Scott | director | 3,000 <0.0001% | $26.47 | $79,401 | +4.23% | ||
| 2023-05-08 | Gottlieb Scott | director | 1,000 <0.0001% | $38.58 | $38,580 | -20.27% | ||
| 2023-05-05 | Gottlieb Scott | director | 1,000 <0.0001% | $38.42 | $38,425 | -19.88% | ||
| 2023-03-15 | Sale | DAMICO JENNIFER B. | SVP & Controller | 9,912 0.0002% | $40.02 | $396,678 | -14.70% | |
| 2022-06-07 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,218 <0.0001% | $53.96 | $227,603 | -14.86% | |
| 2022-05-13 | Sale | SAHNI PAYAL | Executive Vice President | 1,408 <0.0001% | $49.84 | $70,175 | -5.33% | |
| 2022-05-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,000 <0.0001% | $50.50 | $202,000 | -5.33% | |
| 2022-05-12 | Sale | LANKLER DOUGLAS M | Executive Vice President | 38,273 0.0007% | $49.41 | $1.89M | -6.07% | |
| 2022-05-12 | Sale | Carapezzi William R JR | Executive Vice President | 32,908 0.0006% | $50.00 | $1.65M | -6.07% | |
| 2022-05-11 | Sale | Dolsten Mikael | President R&D | 32,015 0.0006% | $49.31 | $1.58M | -3.29% | |
| 2021-12-03 | Sale | JOHNSON RADY A | Executive Vice President | 38,000 0.0007% | $53.42 | $2.03M | -5.95% | |
| 2021-12-02 | Sale | MACKENZIE ALEXANDER R | Executive Vice President | 82,720 0.0015% | $54.26 | $4.49M | -3.77% | |
| 2021-11-26 | Sale | SUSMAN SALLY | Executive Vice President | 88,616 0.0016% | $54.52 | $4.83M | -5.48% | |
| 2021-11-26 | Sale | LANKLER DOUGLAS M | Executive Vice President | 80,000 0.0014% | $54.37 | $4.35M | -5.48% | |
| 2021-11-12 | Sale | Hwang Angela | Group President | 52,340 0.0009% | $49.60 | $2.6M | +2.89% | |
| 2021-11-11 | Sale | YOUNG JOHN D | Group President | 300,000 0.0053% | $50.06 | $15.02M | +1.93% | |
| 2021-11-11 | Sale | Dolsten Mikael | President R&D | 119,328 0.0021% | $50.29 | $6M | +1.93% | |
| 2021-08-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 3,322 <0.0001% | $48.30 | $160,453 | +6.47% | |
| 2021-07-30 | Sale | DAMICO JENNIFER B. | SVP & Controller | 5,000 <0.0001% | $42.86 | $214,300 | +20.14% | |
| 2021-05-05 | Sale | DAMICO JENNIFER B. | SVP & Controller | 5,000 <0.0001% | $40.82 | $204,100 | +23.17% |
Insider Historical Profitability
| Gottlieb Scott | director | 9000 0.0002% | $27.42 | 5 | 0 | <0.0001% |
| MCKINNELL HENRY A | director | 1975066 0.035% | $27.42 | 0 | 2 | |
| STEERE WILLIAM C JR | director | 1480861 0.0262% | $27.42 | 0 | 6 | |
| READ IAN C | Executive Chairman | 1109202 0.0196% | $27.42 | 0 | 10 | |
| KATEN KAREN L | Vice Chairman | 937401 0.0166% | $27.42 | 0 | 3 | |
| SHEDLARZ DAVID L | Vice Chairman | 609310 0.0108% | $27.42 | 0 | 6 | |
| LAMATTINA JOHN L | Senior Vice President | 421101 0.0075% | $27.42 | 0 | 2 | |
| RICCIARDI NATALE S | Senior Vice President | 344431 0.0061% | $27.42 | 0 | 3 | |
| LEVIN ALAN G | Senior Vice President | 340061 0.006% | $27.42 | 0 | 3 | |
| DAMELIO FRANK A | Executive Vice President | 337392 0.006% | $27.42 | 0 | 9 | |
| Dolsten Mikael | President R&D | 333342 0.0059% | $27.42 | 0 | 15 | |
| YOUNG JOHN D | Group President | 312704 0.0055% | $27.42 | 0 | 6 | |
| Germano Geno J | Group President | 263495 0.0047% | $27.42 | 0 | 1 | |
| SCHULMAN AMY W | Former Exec. Vice President | 223497 0.004% | $27.42 | 0 | 2 | |
| BRANDICOURT OLIVIER | Business Unit President | 191076 0.0034% | $27.42 | 0 | 1 | |
| SIMMONS DAVID S | Business Unit President | 134404 0.0024% | $27.42 | 1 | 0 | +21.17% |
| MCLEOD MARY S | Former Sr. Vice President | 121832 0.0022% | $27.42 | 0 | 1 | |
| Lewis-Hall Freda C | Executive Vice President | 118383 0.0021% | $27.42 | 0 | 1 | |
| MADDALUNA ANTHONY J | Executive Vice President | 112087 0.002% | $27.42 | 0 | 5 | |
| SUSMAN SALLY | Executive Vice President | 89575 0.0016% | $27.42 | 1 | 11 | <0.0001% |
| KINDLER JEFFREY B | Former Chairman & CEO | 88084 0.0016% | $27.42 | 0 | 2 | |
| CANGIALOSI LORETTA V | Sr. Vice President, Controller | 83846 0.0015% | $27.42 | 0 | 15 | |
| MACKENZIE ALEXANDER R | Executive Vice President | 87280 0.0015% | $27.42 | 0 | 8 | |
| BOURLA ALBERT | Chairman & CEO | 78273 0.0014% | $27.42 | 0 | 2 | |
| LANKLER DOUGLAS M | Executive Vice President | 78803 0.0014% | $27.42 | 0 | 13 | |
| OLSON LAURIE J | Executive Vice President | 72672 0.0013% | $27.42 | 0 | 6 | |
| HILL CHARLES H | Executive Vice President | 57328 0.001% | $27.42 | 0 | 7 | |
| JOHNSON RADY A | Executive Vice President | 55844 0.001% | $27.42 | 0 | 5 | |
| CORR PETER B | Senior Vice President | 45050 0.0008% | $27.42 | 0 | 1 | |
| PECK KRISTIN C | Executive Vice President | 43400 0.0008% | $27.42 | 0 | 1 | |
| Carapezzi William R JR | Executive Vice President | 38146 0.0007% | $27.42 | 0 | 1 | |
| BURNS M ANTHONY | director | 23989 0.0004% | $27.42 | 0 | 1 | |
| SAHNI PAYAL | Executive Vice President | 17372 0.0003% | $27.42 | 0 | 1 | |
| BURT ROBERT N | director | 12200 0.0002% | $27.42 | 1 | 0 | +18.59% |
| GOETTLER MICHAEL | Group President | 11924 0.0002% | $27.42 | 0 | 1 | |
| BLAYLOCK RONALD E | director | 13000 0.0002% | $27.42 | 1 | 0 | +2.07% |
| DAMICO JENNIFER B. | SVP & Controller | 9003 0.0002% | $27.42 | 0 | 8 | |
| NORA JOHNSON SUZANNE M | director | 10000 0.0002% | $27.42 | 1 | 0 | <0.0001% |
| ROGERS DAWN | Executive Vice President | 4823 0.0001% | $27.42 | 0 | 2 | |
| LUND-JURGENSEN KIRSTEN | Executive Vice President | 4643 0.0001% | $27.42 | 0 | 2 | |
| Hwang Angela | Group President | 1 0% | $27.42 | 0 | 1 | |
| KILTS JAMES M | director | 0 0% | $27.42 | 1 | 5 | <0.0001% |
| SMITH JAMES C | director | 1542 0% | $27.42 | 1 | 1 | +4.56% |
| CORNWELL W DON | director | 0 0% | $27.42 | 3 | 5 | <0.0001% |
| SIMMONS RUTH J | director | 1200 0% | $27.42 | 1 | 0 | <0.0001% |
| FECZKO JOSEPH M | Senior Vice President | 0 0% | $27.42 | 0 | 4 |
Institutional Investor Ownership
| The Vanguard Group | $14.08B | 8.95 | 507.25M | +0.14% | +$20.44M | 0.27 | |
| BlackRock | $11.96B | 7.61 | 431.12M | -0.32% | -$38.44M | 0.27 | |
| State Street | $8.07B | 5.13 | 290.7M | +1.12% | +$89.22M | 0.35 | |
| Wellington Management Company | $4.93B | 3.14 | 177.7M | -25.71% | -$1.71B | 0.84 | |
| Charles Schwab | $3.37B | 2.16 | 122.24M | +17.26% | +$495.97M | 0.76 | |
| Geode Capital Management | $3.14B | 2 | 113.58M | +3.69% | +$112.03M | 0.28 | |
| Capital World Investors | $3.13B | 1.99 | 112.66M | -35.03% | -$1.69B | 0.52 | |
| Morgan Stanley | $2.35B | 1.5 | 84.79M | +3.27% | +$74.54M | 0.18 | |
| Massachusetts Financial Services Co Ma | $1.93B | 1.23 | 69.55M | +1.53% | +$29.03M | 0.58 | |
| Northern Trust | $1.6B | 1.02 | 57.73M | -3.46% | -$57.47M | 0.27 | |
| State Farm | $1.51B | 0.96 | 54.51M | 0% | +$0 | 1.36 | |
| Bank of America | $1.46B | 0.93 | 52.51M | +9.65% | +$128.25M | 0.14 | |
| Legal & General | $1.41B | 0.9 | 50.76M | +2.3% | +$31.64M | 0.33 | |
| Amundi | $1.19B | 0.82 | 46.36M | +8.89% | +$97.05M | 0.5 | |
| BNY Mellon | $1.18B | 0.75 | 42.39M | -3.85% | -$47.06M | 0.22 | |
| JPMorgan Chase | $1.16B | 0.74 | 41.72M | -1.66% | -$19.52M | 0.1 | |
| Dimensional Fund Advisors | $990.39M | 0.63 | 35.69M | -14.97% | -$174.4M | 0.27 | |
| Deutsche Bank | $850.2M | 0.54 | 30.64M | -23.84% | -$266.18M | 0.39 | |
| Invesco | $813.78M | 0.52 | 29.33M | +21.55% | +$144.27M | 0.17 | |
| T. Rowe Price | $697.63M | 0.44 | 25.14M | -17.69% | -$149.96M | 0.09 | |
| Ubs Asset Management Americas Inc | $689.81M | 0.44 | 24.86M | -3.37% | -$24.02M | 0.25 | |
| D. E. Shaw & Co. | $674.13M | 0.43 | 24.29M | +67.28% | +$271.14M | 0.9 | |
| Goldman Sachs | $620.13M | 0.39 | 22.35M | -7.16% | -$47.79M | 0.12 | |
| Barclays | $598.44M | 0.38 | 21.57M | +85.5% | +$275.83M | 0.27 | |
| Wells Fargo | $563.03M | 0.36 | 20.29M | +7.38% | +$38.71M | 0.15 | |
| Franklin Templeton Investments | $551.67M | 0.35 | 19.88M | -3.38% | -$19.3M | 0.17 | |
| Ameriprise Financial | $514.59M | 0.33 | 18.54M | -10.56% | -$60.76M | 0.14 | |
| Royal Bank of Canada | $502.18M | 0.32 | 18.1M | -13.71% | -$79.78M | 0.12 | |
| CalPERS | $491.88M | 0.31 | 17.73M | -2.23% | -$11.21M | 0.35 | |
| Nuveen | $487.4M | 0.31 | 17.56M | -1.71% | -$8.49M | 0.14 | |
| HSBC | $484.35M | 0.31 | 17.46M | +18.81% | +$76.69M | 0.35 | |
| Swiss National Bank | $469.25M | 0.3 | 16.91M | -4.22% | -$20.67M | 0.32 | |
| UBS | $461.11M | 0.29 | 16.62M | +10.37% | +$43.31M | 0.14 | |
| Diamond Hill Investment Group Inc | $446.94M | 0.28 | 16.11M | +36.51% | +$119.53M | 1.83 | |
| VanEck | $438.82M | 0.28 | 15.81M | +21.79% | +$78.51M | 0.67 | |
| Sumitomo Mitsui Trust Holdings | $432.82M | 0.28 | 15.6M | -0.7% | -$3.05M | 0.3 | |
| Neuberger Berman | $423.26M | 0.27 | 15.25M | -13.84% | -$67.99M | 0.35 | |
| Susquehanna International Group | $412.9M | 0.26 | 14.88M | -16.63% | -$82.37M | 0.44 | |
| Bank of Montreal | $412.98M | 0.26 | 14.86M | +11.08% | +$41.2M | 0.13 | |
| Federated Hermes | $401.09M | 0.26 | 14.45M | +8.28% | +$30.68M | 0.93 | |
| First Trust | $398.16M | 0.25 | 14.35M | -29.66% | -$167.85M | 0.41 | |
| Two Sigma Advisers LP | $375.94M | 0.24 | 13.55M | +348.17% | +$292.05M | 0.64 | |
| National Bank Of Canada Fi | $362.4M | 0.23 | 12.94M | +69.11% | +$148.1M | 0.55 | |
| Fidelity Investments | $349.86M | 0.22 | 12.61M | +26.06% | +$72.32M | 0.02 | |
| Citadel Advisors LLC | $347.14M | 0.22 | 12.51M | +7.56% | +$24.41M | 0.23 | |
| LSV Asset Management | $342.86M | 0.22 | 12.36M | -7.21% | -$26.65M | 0.71 | |
| De Depot Et Placement Du Quebec Caisse | $317.28M | 0.2 | 11.43M | -14.99% | -$55.96M | 0.76 | |
| KBC Group | $278.68M | 0.18 | 10.04M | +129.49% | +$157.25M | 0.89 | |
| Envestnet Asset Management Inc | $278.09M | 0.18 | 10.02M | +24.8% | +$55.27M | 0.11 | |
| RhumbLine Advisers | $277.32M | 0.18 | 9.99M | -2.94% | -$8.39M | 0.26 |